Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
CC transcript
Quarterly results
Appointed director
|
|
Viracta Therapeutics, Inc. (VIRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 02/24/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/10/2020 |
10-K
| Annual Report for the period ended December 31, 2019 |
| 03/07/2019 |
10-K
| Annual Report for the period ended December 31, 2018 |
| 03/09/2018 |
10-K
| Annual Report for the period ended December 31, 2017 |
| 03/09/2017 |
10-K
| Annual Report for the period ended December 31, 2016 |
| 03/11/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/12/2015 |
10-K
| Annual Report for the period ended December 31, 2014 |
| 03/06/2014 |
10-K
| Annual Report for the period ended December 31, 2013 |
| 03/13/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/14/2012 |
10-K
| Annual Report for the period ended December 31, 2011 |
| 03/29/2011 |
10-K
| Annual Report for the period ended December 31, 2010 |
| 03/31/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 04/03/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 03/17/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
| 03/15/2007 |
10-K
| Annual Report for the period ended December 31, 2006 |
| 03/29/2006 |
10-K
| Annual Report for the period ended December 31, 2005 |
|
|